History of yellow fever 1,235 fatalities were recorded of an estimated 12,000 cases. Smaller outbreaks occurred in Saint-Nazaire in France, Swansea in Wales, and in other European port cities following the arrival of vessels carrying the mosquito vector. The first mention of the disease by the name "yellow fever" occurred in 1744. Many famous people, mostly during the 18th through the 20th centuries, contracted and then recovered from, or died of, yellow fever. The Yellow Fever Epidemic of 1793 struck during the summer in Philadelphia, Pennsylvania, where the highest fatalities in the United States were recorded. The disease probably was brought by refugees and
Yellow fever vaccine group established in 2000 when a global shortage of yellow fever vaccine had developed because of the long lead time to manufacture the vaccine. As of 2013, there were four WHO-qualified manufacturers: Bio-Manguinhos in Brazil (with the Oswaldo Cruz Foundation), Institute Pasteur in Dakar, Senegal, the Federal State Unitary Enterprise of Chumakov Institute in Russia, and Sanofi Pasteur, the French pharmaceutical company. Two other manufacturers supply domestic markets: Wuhan Institute of Biological Products in China and Sanofi Pasteur in the United States. Seth Berkley, the chief executive of Gavi, has warned about the worldwide threat of yellow fever because of